Short Ideas

[gfp927z]

CHM, Yes, I've been following the Brilacidin saga since the Polymedix days. No position, but defensin mimetics seem like a major breakthrough in antibiotics, and the other indications like oral mucositis and diabetic foot ulcers also look extremely promising.

CTIX needs to raise money soon, so that might be a good time to enter the stock. But biotech is full of landmines, so I'll feel better once the FDA has given the OK for the ABSSSI Phase 3 to start.